Literature DB >> 22595154

Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial.

Kibar Yared1, Tamara Garcia-Camarero, Leticia Fernandez-Friera, Miguel Llano, Ronen Durst, Anil A Reddy, William W O'Neill, Michael H Picard.   

Abstract

OBJECTIVES: Understanding the severity of aortic regurgitation (AR) after transcatheter aortic valve implantation, its impact on left ventricular (LV) structure and function, and the structural factors associated with worsening AR could lead to improvements in patient selection, implantation technique, and valve design.
BACKGROUND: Initial studies in patients at high risk of surgical aortic valve replacement have reported both central valvular and paravalvular AR after transcatheter aortic valve implantation.
METHODS: Transthoracic echocardiograms were quantified from 95 patients in the REVIVAL (TRanscatheter EndoVascular Implantation of VALves) trial. Transthoracic echocardiograms were obtained before implantation of the Edwards-Sapien valve (Edwards Lifesciences, Irvine, California) and thereafter at selected intervals. Measurements included LV internal diameters and volumes, ejection fraction, aortic valve area, and the degree of aortic regurgitation. Measures of degree of native leaflet mobility, thickness, and calcification, as well as left ventricular outflow tract, aortic annulus, and aortic root diameters were also made.
RESULTS: Eighty-four patients remained after 11 were excluded; 26 (29.8%) died over a period of 3 years. At 24 h post-implantation, 75% had some degree of AR, mostly paravalvular. By 1 year, the mean AR grade increased slightly, but not significantly (1.1 ± 0.8 to 1.3 ± 0.9), and all measures of LV structure and function improved (LV ejection fraction, 50.7 ± 16.1% to 59.4 ± 14.0%). Native aortic leaflet calcification and annulus diameter correlated significantly with the severity of AR at 1 year (p < 0.05).
CONCLUSIONS: AR after transcatheter aortic valve implantation is frequent but is rarely more than mild. Although AR progresses, it is not associated with a harmful impact on LV structure and function over the first year. Native valve calcification and aortic annulus diameter influence the degree of AR at 6 months.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595154     DOI: 10.1016/j.jcmg.2012.02.008

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  5 in total

Review 1.  Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status.

Authors:  Sameer Arora; Jacob A Misenheimer; Radhakrishnan Ramaraj
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 2.  Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance.

Authors:  Rebecca T Hahn; Susheel Kodali; Philippe Généreux; Martin Leon
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

3.  Sex Differences in the Impact of Aortic Valve Calcium Score on Mortality After Transcatheter Aortic Valve Replacement.

Authors:  Parth P Patel; Abdallah El Sabbagh; Patrick W Johnson; Rayan Suliman; Najiyah Salwa; Andrea Carolina Morales-Lara; Peter Pollak; Mohamad Yamani; Pragnesh Parikh; Sushilkumar K Sonavane; Carolyn Landolfo; Mohamad Adnan Alkhouli; Mackram F Eleid; Mayra Guerrero; F David Fortuin; John Sweeney; Peter A Noseworthy; Rickey E Carter; Demilade Adedinsewo
Journal:  Circ Cardiovasc Imaging       Date:  2022-08-03       Impact factor: 8.589

Review 4.  Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications.

Authors:  Barbara E Stähli; Willibald Maier; Roberto Corti; Thomas F Lüscher; Rolf Jenni; Felix C Tanner
Journal:  Cardiovasc Diagn Ther       Date:  2013-03

5.  Incidence, Predictors, and Outcome of Paravalvular Leak after Transcatheter Aortic Valve Implantation.

Authors:  Abdullah Hagar; Yijian Li; Xin Wei; Yong Peng; Yuanning Xu; Yuanweixiang Ou; Zijie Wang; Xi Wang; Jageshwar-Prasad Shah; Vivendar Sihag; Mao Chen; Yuan Feng
Journal:  J Interv Cardiol       Date:  2020-05-22       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.